메뉴 건너뛰기




Volumn 18, Issue 3, 2011, Pages 324-330

Prevention of cerebral palsy using magnesium sulfate in pre-term newborns;Prévention de la paralysie cérébrale du grand prématuré par le sulfate de magnésium

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

EID: 79951809576     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2010.12.013     Document Type: Short Survey
Times cited : (10)

References (30)
  • 1
    • 33644819162 scopus 로고    scopus 로고
    • Éditions de l'Inserm, Paris, Expertise collective de l'Inserm
    • Expertise collective de l'Inserm Déficiences et handicaps d'origine périnatale 2004, Éditions de l'Inserm, Paris.
    • (2004) Déficiences et handicaps d'origine périnatale
  • 2
    • 40049098369 scopus 로고    scopus 로고
    • Neurodevelopmental disabilities and special care of 5-year-old children born before 33weeks of gestation (the EPIPAGE study): a cohort longitudinal study
    • Larroque B., Ancel P.Y., Marret S., et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33weeks of gestation (the EPIPAGE study): a cohort longitudinal study. Lancet 2008, 371:813-820.
    • (2008) Lancet , vol.371 , pp. 813-820
    • Larroque, B.1    Ancel, P.Y.2    Marret, S.3
  • 3
    • 72049121445 scopus 로고    scopus 로고
    • Outcomes at age 2years of infants<28weeks'gestational age born in Victoria in 2005
    • Doyle L.W., Roberts G., Anderson P.J., et al. Outcomes at age 2years of infants<28weeks'gestational age born in Victoria in 2005. J Pediatr 2010, 156:49-53.
    • (2010) J Pediatr , vol.156 , pp. 49-53
    • Doyle, L.W.1    Roberts, G.2    Anderson, P.J.3
  • 4
    • 38149116341 scopus 로고    scopus 로고
    • An overview of mortality and sequelae of pre-term birth from infancy to adulthood
    • Saigal S., Doyle L.W. An overview of mortality and sequelae of pre-term birth from infancy to adulthood. Lancet 2008, 371:261-269.
    • (2008) Lancet , vol.371 , pp. 261-269
    • Saigal, S.1    Doyle, L.W.2
  • 5
    • 74049090333 scopus 로고    scopus 로고
    • Prises en charge éducatives spécifiques de l'enfant grand prématuré à 5 et 8ans: résultats de l'étude EPIPAGE
    • Marret S., Ancel P-Y., Marchand L., et al. Prises en charge éducatives spécifiques de l'enfant grand prématuré à 5 et 8ans: résultats de l'étude EPIPAGE. Arch Pediatr 2009, 16:S17-S27.
    • (2009) Arch Pediatr , vol.16
    • Marret, S.1    Ancel, P.-Y.2    Marchand, L.3
  • 6
    • 36849058183 scopus 로고    scopus 로고
    • Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and five-year neurodevelopmental outcomes of very pre-term infants: the EPIPAGE Cohort study
    • Foix-l'Hélias L., Marret S., Ancel P-Y., et al. Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and five-year neurodevelopmental outcomes of very pre-term infants: the EPIPAGE Cohort study. BJOG 2008, 115:275-282.
    • (2008) BJOG , vol.115 , pp. 275-282
    • Foix-l'Hélias, L.1    Marret, S.2    Ancel, P.-Y.3
  • 7
    • 74049123563 scopus 로고    scopus 로고
    • Effects of Prenatal Low-Dose Aspirin on Neurodevelopmental and Behavioral Outcomes of Children Born Very-pre-term: results from the EPIPAGE Study
    • Marret S., Marchand L., Kaminski M., et al. Effects of Prenatal Low-Dose Aspirin on Neurodevelopmental and Behavioral Outcomes of Children Born Very-pre-term: results from the EPIPAGE Study. Pediatrics 2010, 125:e29-e34.
    • (2010) Pediatrics , vol.125
    • Marret, S.1    Marchand, L.2    Kaminski, M.3
  • 8
    • 0036135872 scopus 로고    scopus 로고
    • Melatoninergic neuroprotection of the murine white matter against excitotoxic challenge
    • Husson I., Mesplès B., Bac P., et al. Melatoninergic neuroprotection of the murine white matter against excitotoxic challenge. Ann Neurol 2002, 51:82-92.
    • (2002) Ann Neurol , vol.51 , pp. 82-92
    • Husson, I.1    Mesplès, B.2    Bac, P.3
  • 9
    • 69549108304 scopus 로고    scopus 로고
    • Magnesium sulfate for pre-term labor and pre-term birth
    • for the Society for Maternal-fetal Medicine
    • Mercer B.M., Merlino A.A. Magnesium sulfate for pre-term labor and pre-term birth. Obstet Gynecol 2009, 114:650-668. for the Society for Maternal-fetal Medicine.
    • (2009) Obstet Gynecol , vol.114 , pp. 650-668
    • Mercer, B.M.1    Merlino, A.A.2
  • 10
    • 34249896158 scopus 로고    scopus 로고
    • Antenatal magnesium sulphate neuroprotection in the pre-term infant
    • Marret S., Doyle L.W., Crowther C.A., et al. Antenatal magnesium sulphate neuroprotection in the pre-term infant. Semin Fetal Neonat Med 2007, 12:311-317.
    • (2007) Semin Fetal Neonat Med , vol.12 , pp. 311-317
    • Marret, S.1    Doyle, L.W.2    Crowther, C.A.3
  • 11
    • 0029064353 scopus 로고
    • Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies
    • Marret S., Gressens P., Gadisseux J.F., et al. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol 1995, 37:473-484.
    • (1995) Dev Med Child Neurol , vol.37 , pp. 473-484
    • Marret, S.1    Gressens, P.2    Gadisseux, J.F.3
  • 12
    • 0026542272 scopus 로고
    • Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies
    • Kuban K., Leviton A., Pagano M., et al. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol 1992, 7:70-76.
    • (1992) J Child Neurol , vol.7 , pp. 70-76
    • Kuban, K.1    Leviton, A.2    Pagano, M.3
  • 13
    • 0028939566 scopus 로고
    • Can magnesium sulphate reduce the risk of cerebral palsy in very low birth weight infants?
    • Nelson K.B., Grether J.K. Can magnesium sulphate reduce the risk of cerebral palsy in very low birth weight infants?. Pediatrics 1995, 95:263-269.
    • (1995) Pediatrics , vol.95 , pp. 263-269
    • Nelson, K.B.1    Grether, J.K.2
  • 14
    • 0031842388 scopus 로고    scopus 로고
    • Magnesium sulfate tocolysis and risk of neonatal death
    • Grether J.K., Hoogstrate J., Selvin S., et al. Magnesium sulfate tocolysis and risk of neonatal death. Am J Obstet Gynecol 1998, 178:1-6.
    • (1998) Am J Obstet Gynecol , vol.178 , pp. 1-6
    • Grether, J.K.1    Hoogstrate, J.2    Selvin, S.3
  • 15
    • 0029902517 scopus 로고    scopus 로고
    • Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very lbw children aged 3 to 5years
    • Schendel D.E., Berg C.J., Yeargin-Allsopp M., et al. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very lbw children aged 3 to 5years. JAMA 1996, 276:1805-1810.
    • (1996) JAMA , vol.276 , pp. 1805-1810
    • Schendel, D.E.1    Berg, C.J.2    Yeargin-Allsopp, M.3
  • 16
    • 0034937843 scopus 로고    scopus 로고
    • Effect of maternal tocolysis on the incidence of severe periventricular/IVH in very low birth weight infants
    • Weintraub Z., Solovechick M., Reichman B., et al. Effect of maternal tocolysis on the incidence of severe periventricular/IVH in very low birth weight infants. Arch Dis Child Fetal and Neonat Ed 2001, 85:F13-F17.
    • (2001) Arch Dis Child Fetal and Neonat Ed , vol.85
    • Weintraub, Z.1    Solovechick, M.2    Reichman, B.3
  • 17
    • 0033825505 scopus 로고    scopus 로고
    • Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia
    • Grether J.K., Hoogstrate J., Walsh-Greene E., et al. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol 2000, 183:717-725.
    • (2000) Am J Obstet Gynecol , vol.183 , pp. 717-725
    • Grether, J.K.1    Hoogstrate, J.2    Walsh-Greene, E.3
  • 18
    • 0036085123 scopus 로고    scopus 로고
    • Association between the use of magnesium sulfate in pre-term labor and adverse health outcomes in infants
    • Mittendorf R., Dambrosia J., Pryde P.G., et al. Association between the use of magnesium sulfate in pre-term labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002, 186:1111-1118.
    • (2002) Am J Obstet Gynecol , vol.186 , pp. 1111-1118
    • Mittendorf, R.1    Dambrosia, J.2    Pryde, P.G.3
  • 19
    • 0345374593 scopus 로고    scopus 로고
    • Effect of magnesium sulphate given for neuroprotection before pre-term birth: a randomised-controlled trial
    • Crowther C.A., Hiller J.E., Doyle L.W., et al. Effect of magnesium sulphate given for neuroprotection before pre-term birth: a randomised-controlled trial. JAMA 2003, 290:2669-2676.
    • (2003) JAMA , vol.290 , pp. 2669-2676
    • Crowther, C.A.1    Hiller, J.E.2    Doyle, L.W.3
  • 20
    • 33847007984 scopus 로고    scopus 로고
    • Magnesium sulphate given before very pre-term birth to protect infant brain: the randomised-controlled PREMAG trial
    • Marret S., Marpeau L., Zupan-Simunek V., et al. Magnesium sulphate given before very pre-term birth to protect infant brain: the randomised-controlled PREMAG trial. BJOG 2007, 114:310-318.
    • (2007) BJOG , vol.114 , pp. 310-318
    • Marret, S.1    Marpeau, L.2    Zupan-Simunek, V.3
  • 21
    • 38049091949 scopus 로고    scopus 로고
    • Benefit of magnesium sulfate given before very pre-term birth to protect infant brain
    • Marret S., Marpeau L., Bénichou J. Benefit of magnesium sulfate given before very pre-term birth to protect infant brain. Pediatrics 2008, 121:225-226.
    • (2008) Pediatrics , vol.121 , pp. 225-226
    • Marret, S.1    Marpeau, L.2    Bénichou, J.3
  • 22
    • 40949144801 scopus 로고    scopus 로고
    • Effet du sulfate de magnésium sur la mortalité et la morbidité neurologique chez le prématuré de moins de trente-trois semaines, avec recul à deux ans: résultats de l'essai prospectif multicentrique contre placebo PREMAG
    • Marret S., Marpeau L., Follet-Bouhamed C., et al. Effet du sulfate de magnésium sur la mortalité et la morbidité neurologique chez le prématuré de moins de trente-trois semaines, avec recul à deux ans: résultats de l'essai prospectif multicentrique contre placebo PREMAG. Gynecol Obstet Fertil 2008, 36:278-288.
    • (2008) Gynecol Obstet Fertil , vol.36 , pp. 278-288
    • Marret, S.1    Marpeau, L.2    Follet-Bouhamed, C.3
  • 23
    • 50449093260 scopus 로고    scopus 로고
    • A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy
    • Rouse D.J., Hirtz D.G., Thom E., et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008, 359:895-905.
    • (2008) N Engl J Med , vol.359 , pp. 895-905
    • Rouse, D.J.1    Hirtz, D.G.2    Thom, E.3
  • 24
    • 0036606736 scopus 로고    scopus 로고
    • Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial
    • The Magpie Trial Collaborative Group
    • The Magpie Trial Collaborative Group Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002, 359:1877-1890.
    • (2002) Lancet , vol.359 , pp. 1877-1890
  • 25
    • 0032145390 scopus 로고    scopus 로고
    • If tocolytic magnesium sulphate is associated with excess total pediatric mortality, what is its impact?
    • Mittendorf R., Pryde P., Khoshnood B., et al. If tocolytic magnesium sulphate is associated with excess total pediatric mortality, what is its impact?. Obstet Gynecol 1998, 92:308-311.
    • (1998) Obstet Gynecol , vol.92 , pp. 308-311
    • Mittendorf, R.1    Pryde, P.2    Khoshnood, B.3
  • 26
    • 17144458130 scopus 로고    scopus 로고
    • Tocolytic magnesium sulphate and paediatric mortality
    • Benichou J., Zupan V., Fernandez H., et al. Tocolytic magnesium sulphate and paediatric mortality. Lancet 1998, 351:290-291.
    • (1998) Lancet , vol.351 , pp. 290-291
    • Benichou, J.1    Zupan, V.2    Fernandez, H.3
  • 27
    • 85048735717 scopus 로고    scopus 로고
    • Antenatal magnesium sulphate neuroprotection in the pre-term infant
    • Doyle L.W., Crowther C.A., Middleton P., et al. Antenatal magnesium sulphate neuroprotection in the pre-term infant. Cochrane Database Syst Rev 2009, 3:CD004661.
    • (2009) Cochrane Database Syst Rev , vol.3
    • Doyle, L.W.1    Crowther, C.A.2    Middleton, P.3
  • 28
    • 66649083892 scopus 로고    scopus 로고
    • Antenatal magnesium sulphate and neurologic outcome in pre-term infants
    • Doyle L.W., Crowther C.A., Middleton P., et al. Antenatal magnesium sulphate and neurologic outcome in pre-term infants. Obstet Gynecol 2009, 113:1327-1333.
    • (2009) Obstet Gynecol , vol.113 , pp. 1327-1333
    • Doyle, L.W.1    Crowther, C.A.2    Middleton, P.3
  • 29
    • 66149146655 scopus 로고    scopus 로고
    • Antenatal magnesium sulfate for the prevention of cerebral palsy in pre-term infants less than 34weeks'gestation: a systematic review and meta-analysis
    • Conde-Agudelo A., Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in pre-term infants less than 34weeks'gestation: a systematic review and meta-analysis. Am J Obstet Gynecol 2009, 200:595-609.
    • (2009) Am J Obstet Gynecol , vol.200 , pp. 595-609
    • Conde-Agudelo, A.1    Romero, R.2
  • 30
    • 68949111738 scopus 로고    scopus 로고
    • Effects of Antenatal Exposure to Magnesium Sulfate on Neuroprotection and Mortality in Preterm Infants. A Meta-analysis
    • for the Eunice Kennedy Shriver National Institute of Child health and Human Development Maternal-Fetal Medicine Units Network
    • Costantine M.M., Weiner S.J. Effects of Antenatal Exposure to Magnesium Sulfate on Neuroprotection and Mortality in Preterm Infants. A Meta-analysis. Obstet Gynecol 2009, 114:354-364. for the Eunice Kennedy Shriver National Institute of Child health and Human Development Maternal-Fetal Medicine Units Network.
    • (2009) Obstet Gynecol , vol.114 , pp. 354-364
    • Costantine, M.M.1    Weiner, S.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.